This interim guidance is intended to assist clinicians in the management of patients with severe infections who may develop acute respiratory failure or septic shock. The guidance lists interventions that may be beneficial to patients and interventions that should not be undertaken.
This is a Japanese translation of a World Health Organization interim guidance document on the clinical management of suspected severe acute respiratory infection (SARI) with novel coronavirus infection. It is organized into four sections: early detection and management; management of severe dyspnea, hypoxemia and ARDS; management of septic shock; and prevention of complications. The document uses symbols for Do, Don't and procedures requiring caution.
The guidance is intended for clinicians caring for patients with severe manifestations of SARI, including doctors working in intensive care units with limited equipment for mechanical ventilation, invasive hemodynamic monitoring or blood gas analysis. It states that all confirmed cases reported to date were adults and that management for children may be added later. References and acknowledgements are included. This manual is written in Japanese.
For significant dyspnea, hypoxemia with SpO2 below 90%, or shock, oxygen should be given and the dose set to a target SpO2 of 92–95%.
Yes. The guidance says all confirmed cases reported to date were adults, so it focuses on care for adolescents and adults.
The interim guidance is valid for 12 months from the date it is publicly announced.